---
figid: PMC8524703__etm-22-06-10844-g00
figtitle: 'Glioblastoma pharmacotherapy: A multifaceted perspective of conventional
  and emerging treatments (Review)'
organisms:
- Adenoviridae
- Human alphaherpesvirus 1
- H-1 parvovirus
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Danio rerio
pmcid: PMC8524703
filename: etm-22-06-10844-g00.jpg
figlink: /pmc/articles/PMC8524703/figure/f1-ETM-22-6-10844/
number: F1
caption: Glioblastoma multiforme signalling pathways. PDGFRA, platelet-derived growth
  factor receptor A; FGFR, fibroblast growth factor receptor; INSR, insulin receptor;
  NF1, neurofibromin 1; MAPK, mitogen-activated protein kinase; PIK3CA, phosphatidylinositol-4,5-bisphosphate
  3-kinase catalytic subunit alpha; KRIT1, Krev interaction trapped; RTK, receptor
  tyrosin kinase; CDKN2A/B/C, cyclin-dependent kinase inhibitor 2A/B/C; CDK4/6, cyclin-dependent
  kinase 4/6; Rb1, retinoblastoma protein 1; MDM2/4, mouse double minute 2/4 homolog;
  KLLN, killin. Block arrow, inhibition; point arrow, pathway flow.
papertitle: 'Glioblastoma pharmacotherapy: A multifaceted perspective of conventional
  and emerging treatments (Review).'
reftext: Ani-Simona Sevastre, et al. Exp Ther Med. 2021 Dec;22(6):1408.
year: '2021'
doi: 10.3892/etm.2021.10844
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords: glioblastoma | pathways | targeted therapy | pharmaceutics | clinical trials
automl_pathway: 0.9013545
figid_alias: PMC8524703__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
redirect_from: /figures/PMC8524703__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8524703__etm-22-06-10844-g00.html
  '@type': Dataset
  description: Glioblastoma multiforme signalling pathways. PDGFRA, platelet-derived
    growth factor receptor A; FGFR, fibroblast growth factor receptor; INSR, insulin
    receptor; NF1, neurofibromin 1; MAPK, mitogen-activated protein kinase; PIK3CA,
    phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; KRIT1,
    Krev interaction trapped; RTK, receptor tyrosin kinase; CDKN2A/B/C, cyclin-dependent
    kinase inhibitor 2A/B/C; CDK4/6, cyclin-dependent kinase 4/6; Rb1, retinoblastoma
    protein 1; MDM2/4, mouse double minute 2/4 homolog; KLLN, killin. Block arrow,
    inhibition; point arrow, pathway flow.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - PDGFRA
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - MET
  - KDR
  - FLT1
  - FLT4
  - CDKN2A
  - CDKN2B
  - CDKN2C
  - MDM2
  - NF1
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - KRIT1
  - CDK4
  - CDK6
  - TP53
  - MDM4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KLLN
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - RB1
  - RBM45
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TP63
  - TP73
  - Egfr
  - Pdgfra
  - Met
  - Cdkn2a
  - Cdkn2b
  - Cdkn2c
  - Mdm2
  - Nf1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pten
  - Krit1
  - Cdk4
  - Cdk6
  - Trp53
  - Mdm4
  - Zhx2
  - Akt1
  - Mdk
  - Mtor
  - Parp1
  - Rb1
  - Pik3r1
  - egfra
  - pdgfra
  - cdkn2c
  - mdm2
  - nf1a
  - rab1ab
  - ptenb
  - krit1
  - cdk4
  - cdk6
  - tp53
  - mdm4
  - mtor
  - parp14rs2.1
  - rb1
---
